Population pharmacokinetics of naringin in total flavonoids of Drynaria Fortunei (Kunze) J. Sm. in Chinese women with primary osteoporosis

Chinese Journal of Integrative Medicine

Volumn 18, Issue 12, 2012, Pages 925-933

  Wang, Jian Nong ^a   Jiang, Jun Jie ^b   Xie, Yan Ming ^b   Wei, Xu ^b   Li, Jian Peng ^b   Duan, Jing Li ^c   Xiong, Xin ^c  

^a XIYUAN HOSPITAL   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

naringin; population pharmacokinetics; Qianggu Capsule; total flavonoids of Drynaria fortunei

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AURANTIIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; CHINESE; COMMUNITY; COMPARTMENT MODEL; COMPUTER PROGRAM; COVARIANCE; CREATININE BLOOD LEVEL; DATA ANALYSIS; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG CAPSULE; DRUG CLEARANCE; DRUG EFFECT; DRYNARIA FORTUNEI; FEMALE; HUMAN; HYPERLIPIDEMIA; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MEDICINAL PLANT; NONLINEAR SYSTEM; PRIMARY OSTEOPOROSIS; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CHINA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLAVANONES; FLAVONOIDS; HUMANS; MIDDLE AGED; OSTEOPOROSIS; POLYPODIACEAE; TANDEM MASS SPECTROMETRY;

EID: 84874459577     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-012-1296-0     Document Type: Article

References (9)

1. Pharmacopoeia Commission of People's Republic of China (Chinese ed). Vol. I. Pharmacopoeia of the People's Republic of China. Beijing: Chemical Industry Press; 2005:179-180.
2. Li XH, Xiong ZhL, Lu Sh, Zhang Y, Li FM. Pharmacokinetics of naringin and its metabolite naringenin in rats after oral administration of rhizoma Drynariae extract assayed by UPLC-MS/MS. Chin J Nat Med 2010;8:40-46.
3. Su L, Liu QD. Biological activity and pharmacokinetics of Naringin. Guangzhou Univ Chin Med (Chin) 2008;2:74-80.
4. China Association of Medicine, 1st ed. Guideline of clinical diagnosis: subvolume of osteoporosis and born minral salt diseases. Beijing: People's health press; 2010:1-7.
5. Ishii K, Furuta T, Kasuya Y. Determination of naringin and naringenin in human plasma by high-performance liquid chromatography. J Chromatogr B 1996;683:225-229.
6. Ishii K, Furuta T, Kasuya Y. Determination of naringin and naringenin in human urine by high-performance liquid chromatography utilizing solid-phase extraction. J Chromatogr B 1997;704:299-305.
7. Fang T, Wang T, Ma Y, Su W, Bai Y, Zhao P. A. rapid LC/MS/MS quantitation assay for naringin and itstwo metabolites in rats plasma. J Pharm Biomed Anal 2006;40:454-459.
8. Food and Drug Adminstration. Guidance for Industry Population Pharmacokinetics 1999.
9. Sheiner LB, Rosenberg B, Marathe VV. Estimation of population Characteristics of pharmacokinetics parameters from routine clinical data. J Pharmacokinet Biopharm 1977;5:445-479.